These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 36502606)

  • 21. Targeting Cytochrome P450 (CYP) 1B1 Enzyme with Four Series of A-Ring Substituted Estrane Derivatives: Design, Synthesis, Inhibitory Activity, and Selectivity.
    Dutour R; Roy J; Cortés-Benítez F; Maltais R; Poirier D
    J Med Chem; 2018 Oct; 61(20):9229-9245. PubMed ID: 30216063
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative CYP1A1 and CYP1B1 substrate and inhibitor profile of dietary flavonoids.
    Androutsopoulos VP; Papakyriakou A; Vourloumis D; Spandidos DA
    Bioorg Med Chem; 2011 May; 19(9):2842-9. PubMed ID: 21482471
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis, biological evaluation and docking studies of trans-stilbene methylthio derivatives as cytochromes P450 family 1 inhibitors.
    Wierzchowski M; Dutkiewicz Z; Gielara-Korzańska A; Korzański A; Teubert A; Teżyk A; Stefański T; Baer-Dubowska W; Mikstacka R
    Chem Biol Drug Des; 2017 Dec; 90(6):1226-1236. PubMed ID: 28632937
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytochrome P450 1A1 and 1B1 in human blood lymphocytes are not suitable as biomarkers of exposure to dioxin-like compounds: polymorphisms and interindividual variation in expression and inducibility.
    van Duursen MB; Sanderson JT; van den Berg M
    Toxicol Sci; 2005 May; 85(1):703-12. PubMed ID: 15659568
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of human CYP1 enzymes by a classical inhibitor α-naphthoflavone and a novel inhibitor N-(3, 5-dichlorophenyl)cyclopropanecarboxamide: An in vitro and in silico study.
    Juvonen RO; Jokinen EM; Javaid A; Lehtonen M; Raunio H; Pentikäinen OT
    Chem Biol Drug Des; 2020 May; 95(5):520-533. PubMed ID: 32060993
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative Inhibitory Effects of Natural Biflavones from Ginkgo against Human CYP1B1 in Recombinant Enzymes and MCF-7 Cells.
    Chen X; Zhao T; Du J; Guan X; Yu H; Wang D; Wang C; Meng Q; Yao J; Sun H; Liu K; Wu J
    Planta Med; 2023 Apr; 89(4):397-407. PubMed ID: 36064115
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 3D-QSAR assisted identification of selective CYP1B1 inhibitors: an effective bioisosteric replacement/molecular docking/electrostatic complementarity analysis.
    Raju B; Sapra B; Silakari O
    Mol Divers; 2023 Dec; 27(6):2673-2693. PubMed ID: 36441444
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of CYP1B1-specific candidate inhibitors using combination of in silico screening, integrated knowledge-based filtering, and molecular dynamics simulations.
    Kumar R; Gupta D
    Chem Biol Drug Des; 2016 Nov; 88(5):730-739. PubMed ID: 27300691
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and biological evaluation of pyrrole-based chalcones as CYP1 enzyme inhibitors, for possible prevention of cancer and overcoming cisplatin resistance.
    Williams IS; Joshi P; Gatchie L; Sharma M; Satti NK; Vishwakarma RA; Chaudhuri B; Bharate SB
    Bioorg Med Chem Lett; 2017 Aug; 27(16):3683-3687. PubMed ID: 28711350
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design of Cytochrome P450 1B1 Inhibitors
    Hachey AC; Fenton AD; Heidary DK; Glazer EC
    J Med Chem; 2023 Jan; 66(1):398-412. PubMed ID: 36520541
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Overcoming Taxol-resistance in A549 cells: A comprehensive strategy of targeting P-gp transporter, AKT/ERK pathways, and cytochrome P450 enzyme CYP1B1 by 4-hydroxyemodin.
    Lin H; Hu B; He X; Mao J; Wang Y; Wang J; Zhang T; Zheng J; Peng Y; Zhang F
    Biochem Pharmacol; 2020 Jan; 171():113733. PubMed ID: 31783010
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Discovery and characterization of novel CYP1B1 inhibitors based on heterocyclic chalcones: Overcoming cisplatin resistance in CYP1B1-overexpressing lines.
    Horley NJ; Beresford KJ; Chawla T; McCann GJ; Ruparelia KC; Gatchie L; Sonawane VR; Williams IS; Tan HL; Joshi P; Bharate SS; Kumar V; Bharate SB; Chaudhuri B
    Eur J Med Chem; 2017 Mar; 129():159-174. PubMed ID: 28222316
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design of Novel 2-Phenylquinazolin-4-amines as Selective CYP1B1 Inhibitors for Overcoming Paclitaxel Resistance in A549 Cells.
    Yang M; Yang F; Huang X; Cai J; Zhang Y; Jia J; Qiu D
    J Med Chem; 2024 Apr; 67(7):5883-5901. PubMed ID: 38509663
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predicting drug metabolism by CYP1A1, CYP1A2, and CYP1B1: insights from MetaSite, molecular docking and quantum chemical calculations.
    Pragyan P; Kesharwani SS; Nandekar PP; Rathod V; Sangamwar AT
    Mol Divers; 2014 Nov; 18(4):865-78. PubMed ID: 25028215
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Carvedilol serves as a novel CYP1B1 inhibitor, a systematic drug repurposing approach through structure-based virtual screening and experimental verification.
    Wang Y; He X; Li C; Ma Y; Xue W; Hu B; Wang J; Zhang T; Zhang F
    Eur J Med Chem; 2020 May; 193():112235. PubMed ID: 32203789
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correlation between CYP1A1 transcript, protein level, enzyme activity and DNA adduct formation in normal human mammary epithelial cell strains exposed to benzo[a]pyrene.
    Divi RL; Lindeman TL; Shockley ME; Keshava C; Weston A; Poirier MC
    Mutagenesis; 2014 Nov; 29(6):409-17. PubMed ID: 25245543
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Selective inhibition of methoxyflavonoids on human CYP1B1 activity.
    Takemura H; Itoh T; Yamamoto K; Sakakibara H; Shimoi K
    Bioorg Med Chem; 2010 Sep; 18(17):6310-5. PubMed ID: 20696580
    [TBL] [Abstract][Full Text] [Related]  

  • 38. α-naphthoflavone-derived cytochrome P450 (CYP)1B1 degraders specific for sensitizing CYP1B1-mediated drug resistance to prostate cancer DU145: Structure activity relationship.
    Chen P; Wang S; Cao C; Ye W; Wang M; Zhou C; Chen W; Zhang X; Zhang K; Zhou W
    Bioorg Chem; 2021 Nov; 116():105295. PubMed ID: 34455300
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of 2-arylbenzo[
    Dong J; Wang Z; Meng Q; Zhang Q; Huang G; Cui J; Li S
    RSC Adv; 2018 Apr; 8(27):15009-15020. PubMed ID: 35541321
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preferential induction of cytochrome P450 1A1 over cytochrome P450 1B1 in human breast epithelial cells following exposure to quercetin.
    Mense SM; Chhabra J; Bhat HK
    J Steroid Biochem Mol Biol; 2008 May; 110(1-2):157-62. PubMed ID: 18456490
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.